A 20-year-old womanwith IgA nephropathy was admitted to Jikei University Hospital for the treatment of rapid deterioration of renal function after receiving 131I-therapy against hyperthyroidism on October 23, 1999, and hemodialysis was started. On admission, she was diagnosed as having Evans' syndrome in addition to known Graves9 disease. Renal biopsy revealed end-stage renal damage, then, hemodialysis was maintained. Treatment for Evans9 syndromewas also started and her general condition gradually improved. The present case implied that "Graves9 disease99 and "Evans9 syndrome99 could represent some of the manifestations of an underlying immunological disorder in the patient.
Introduction
Graves' disease is clinically characterized by diffuse goiter, thyrotoxicosis, infiltrative orbitopathy, and occasionally infiltrative dermatopathy; the circulating antibody specific to Graves' disease is the antibody against thyroid stimulating hormone (TSH) receptor (TSHRAb). In addition, Graves' disease is reported to be occasionally complicated by hematological disorders, such as thrombocytopeniaand/or hemolytic anemia (1) (2) (3) (4) (5) (6) (7) . Recently, some groups reported that patients with thyroid diseases were complicated by renal diseases (8-10). Although the exact relationship between Graves' disease and IgA nephropathy is unclear, we recently encountered a case of Graves' disease and IgA nephropathy complicated by autoimmune hemolytic anemia (AIHA), idiopathic thrombocytopenic purpura (ITP) (so-called Evans' syndrome (1 1)), and rapid deterioration of renal failure. Although the previous reports (4, 1 2) suggested that thrombocytopenia in a hyperthyroid patient could be caused by thyrotoxicosis-induced reticuloendothelial activation, the present case was complicated by thrombocytopenia without thyrotoxicosis. Herein, wediscuss the clinical aspects of the present case.
Case Report
A 20-year-old woman, who had been diagnosed as IgA nephropathy since the age of 13 years was admitted to Jikei University Hospital for maintaining hemodialysis due to rapid progression of renal failure. An annual medical check at her school at age 13 revealed the chance for proteinuria and hematuria. Then she consulted the department of pediatrics of Jikei University Hospital and she was diagnosed as IgA nephropathy by renal biopsy (Fig.  1A) . But since that time she had not consulted the department of pediatrics of our hospital and her IgA nephropathy could not be followed up. She consulted the outpatient clinic of internal medicine of Jikei University Hospital, complaining of slight fever, weight loss, and general fatigue on December ll, 1998 and was diagnosed as hyperthyroidism due to Graves' disease. Her hemoglobin concentration was 8.6 g/dl, platelet count 196,000/|il, and her serum creatinine level 0.9 mg/dl. She was treated with methimazol (MMI) but she self-discontinued MMIin April, 1999, because of a skin allergic reaction. On May 13, 1999, she was admitted to another hospital for thyroid crisis and treated with propylthiouracil (PTU). But a skin allergic reaction appeared again. On admission, her serum creatinine level was 1.1 mg/dl, and was elevated to 1.25 mg/dl when she was discharged from that hospital in June (her creatinine levels remained between 0.9 mg/dl to 1.25 mg/dl during hospitalization). Creatinine clearance was 44 ml/min on June 7. Overall, thyroidectomy was recommended, but she refused the operation, and finally, radioisotope therapy with 131I (6 mCi) was performed. She did not consult a doctor after radioisotope therapy and renal function was not regularly followed up. On October 19, 1999, she was hospitalized emergently, complaining of dyspnea due to pulmonary edema and renal failure, and hemodialysis was immediately started. After her general conditions were improved, she was referred to Jikei University Hospital for maintenance hemodialysis on October 23. She had no particular family histories. She also had no past history of blood transfusion. On physical findings, body temperature was 36.8°C, blood pressure 142/80 mmHg,and heart rate 88 beats/min. Her palpebral conjunctiva was anemic, but hepatosplenomegly, and pretibial pitting edema were not observed. She did not complain of arthralgia. Eyes and oral cavity were not dry. No skin lesion or photosensitivity, which are someof the diagnostic criteria of collagen disease, wasnoticed. Thyroid gland was diffusely enlarged and elastic soft without tenderness. Laboratory findings showed normochromic normocytic anemia (Hb 8.7 g/dl) with marked increase of reticulocytes, positive for direct and indirect Coombs' tests, decrease of serum haptoglobin levels, positive for anti-platelet antibody, and few tear dropped and fragmented red blood cells in peripheral blood smear, as shown in Fig. 2A . Warm-active antibody was IgG. In addition, gastro-intestinal hemorrhage was denied by endoscopic examinations in spite of progression of anemia, leading to the diagnosis ofAIHA (Tables 1 , 2) . Serum IgG, IgA, and IgM were 1,674 mg/dl, 491 mg/dl, and 87 mg/dl, respectively, and myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA) was 14 EU (normal range; <10 EU). Proteinase-3 ANCAwas less than 10 EU. Platelet associate IgG (PA IgG) was 156.0 ng/107 cells (Table 3 ). Bone marrowaspiration revealed that bonemarrowcells were 1.34xlO7nl (normal range; 1.0-2.0xl05/p.l) and megakaryocytes were 47/^.1 (normal range; 50-150/(il) in bone marrow blood (Fig. 2B-D) . Thyroid function tests revealed mild elevation of serum TSH level. TSHRAbwas 36.1% (normal range; <15%) and thyroid stimulating antibody was 1 15% (normal range; <180%). Anti-thyroid antibodies were markedly elevated as shown in Table 3 strongly positive (x320, speckled and homogeneouspatterns) but other autoimmune antibodies associated with collagen diseases were negative except anti-SS-A/Ro antibody. Both the Wassermanntest and the Treponema pallidum hemagglutination test were negative. Anti-cardiolipine antibody (IgG) was less than 8 U/ml and anti-cardiolipine IgM antibody was negative. Lymphocyte stimulation tests with MMI (Mercazole®; Chugai pharmacoceutical Co., Ltd.) and PTU (Propacil®; Chugai Pharmacoceutical Co. , Ltd.) were both negative (Table  2) . Although platelet count on admission to our hospital was not decreased and purpura was not observed on her skin, bleeding time was prolonged to more than 10 minutes. Because fibrinogen degradation products (FDP) and D-dimer were markedly increased on admission, disseminated intravascular coagulation (DIC) was considered despite the unsatisfactory results of laboratory findings to diagnose as DIC. But platelet count in peripheral blood had been decreased in spite of improvement of FDPand D-dimer by treating with continuous infusion of 240 mg/day nafamostat mesilate. Then, her thrombocytopenia wasconsidered due to ITP and she wasdiagnosed as Evans' syndrome. Ultrasonographic findings of her neck revealed a slightly enlarged thyroid gland. Urinalysis was positive for urinary protein (3+) and granular cast (1+). Daily urinary protein excretion was 9.9 g/day. Microhematuria (RBCs in urine were 30-49 per high power field) was also noticed. Abdominal X-ray examination, ultrasonography, and abdominal computed tomography confirmed that the size of both kidneys was within the normal limit. Finally, renal biopsy was performed on November2 to investigate the cause of renal failure and the possibility to recover renal function. But renal biopsy revealed that 1 1 out of 13 glomeruli in the biopsy specimenhad already become global sclerosis, adhesion was recognized in 2 glomeruli without crescentic lesions, interstitial infiltration of lymphocytes and macrophages, and arteriole intima had become hyperplasic, indicating intravascular hypertension. But immunohistostaining of glomeruli were negative for immunoglobulins except IgM and C3; there was no evidence of vasculitis, and no lesions specific to lupus nephritis. According to these findings, the renal biopsy specimen was considered to be compatible with pauci-immune type MPO-ANCA-related nephritis (Fig. 1B-D) . Thus, it was considered that hemodialysis should be maintained. Prednisolone (PSL) Thrombocytopenia which was presented after admission was considered as a manifestation of ITP according to clinical findings and responses for treatment. DICwas also considered, but, thereafter, thrombocytopenia was assumed to be independent of DICfrom the view of the responses to treatment by nafamostat mesilate (Fig. 3) . Another possible cause of thrombocytopenia might be collagen diseases, such as systemic lupus erythematosus (SLE) or Sjogren's syndrome. While anti-SS-A/Ro antibody and ANAwere positive in the present case, the symptomsdue to collagen diseases, such as skin lesions, arthralgia, and photosensitivity, were absent. In addition, ANA and anti-SS-A/Ro antibody are often positive in patients with ITP who do not develop SLE or Sjogren's syndrome (18) . So the present case was unlikely to satisfy the criteria of collagen disease, such as SLE and Sjogren syndrome. Based on these findings, thrombocytopenia in the present case could be most likely due to ITP, but not due to collagen disease. Although thrombocytopenia in Graves' disease is generally assumed to be due to thyrotoxicosis-induced reticuloendothelial activation (4, 12) , thrombocytopenia in the present case did not seem to occur from thyrotoxicosis-induced reticuloendothelial activation based on her clinical course (Fig. 3) . In addition, the platelet count in the clinical course of our patient also seemedto be related to PAIgG. Thus, although ITP which was incidentally complicated could not be ruled out, this fact might imply that Graves* disease had potential to complicate thrombocytopenia by an underlying immunological mechanism, not by thyrotoxicosis.
As for the causes of renal dysfunction during treatment for Graves' disease, anti-thyroid drugs should be mentioned (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) . Onthe other hand, previous case reports suggested that some kinds of renal diseases could be complicated by thyroid diseases and that thyroid tissue might serve as a continuous source of antigen for the formation of the nephritogenic circulating immunecomplexes consisting of thyroid constituents and antibody (8-10). In addition, our patient had a past history of IgA nephropathy, which was thought to have immunologi- cal background (30) . In the present case, the titer of anti-thyroid antibodies were high and MPO-ANCA wasslightly above the normalrange. In addition, hypertensionsecondaryto renal dysfunctionmightfacilitate the progressionof renal failure. Becauseseveral possible causes of renal failure wereraised as mentionedabove,causeof renal failure in the presentcase is a matter of great interest. But, unfortunately, there are fewdata to explain the cause of renal failure becausethe histological findingswerenon-specificrelated to these causes, andthe detailed clinical course of renal failure in the present case was not available. In summary, wereported a case of Graves' disease complicated by Evans' syndromeand rapid progression of renal failure in a patient with IgAnephropathy. Apartfromthe causeof renal failure, immunological disorders wassuspected to be associated with the critical cause underlying Graves' disease and Evans' syndromein the present case. In addition, because Evans' syndrome occurredwithoutthyrotoxicosis in the present case, it indicates that complicationsin patients with Graves' disease, such as Evans' syndrome,could occur independentof thyrotoxicosis. Thus, althoughfurther study should be required, the present case implied that "Graves' disease", "Evans' syndrome", and other immunological complicationsof "Graves' disease" couldrepresentsomeof the manifestations of the anunderlying immunologicaldisorder of "Graves' disease" rather than complicationsof "Graves' disease" itself. 
